USPTO serial 79332380
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in science; biological preparations for use in industry and science, in particular, biologically active substances, proteins, nucleic acids; kits for biotechnological and chemical research purposes composed of reagents and assay samples; biological preparation for use in cell cultures other than for medical or veterinary use; cell culture media for use in non-medical research laboratories; cell culture media for use in the biotechnological industry for scientific and research use; cell growth media for growing cells for scientific use; reconstituted cells for the tolerance testing of pharmaceutical products for scientific and research purposes; reconstituted cells for the efficiency testing of pharmaceutical products for scientific and research purposes; cell culture reagents for scientific and research use; cell culture media for scientific and research use; stem cells for research or scientific purposes; stem cell cultures for scientific or research use; cell cultures for scientific or research use; cell aggregate cultures for scientific or research use; biological tissue cultures for scientific or research use | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, sample carriers and pipetting and dispensing devices, and optical instruments, being laboratory apparatus for research and industrial applications, for use in the fields of biotechnology, pharmacy, medicine, diagnostics and chemistry, namely, apparatus and instruments for microscopy for use in connection with the generation of three dimensional tissue and cell models and automated high-throughput pipetting systems, including manual, semi-automated, and automated pipetting systems; scientific apparatus and instruments, for use in the field of development and manufacture of biotechnological goods, biotechnological processes, pharmaceutical goods, pharmaceutical processes, diagnostic products, diagnostic processes, namely, microfluidic technology-based chips which enable investigators to perform co-cultures of multiple cell and tissue types in 3-D with high-throughput screening capabilities for biomedical research and drug discovery; data carriers containing downloadable and recorded computer programs for carrying out high-throughput screening, tissue and cell modeling, scientific investigations and experiments, and to evaluate the results in the biotechnology, pharmaceutical fields, medicine, diagnosticschemical fields; downloadable and recorded software programs for evaluating experimental data derived from for high-throughput screening, tissue and cell modeling for use in the biotechnology, pharmaceutical fields, medicine, and diagnosticschemical fields; testware, namely, recorded and downloadable software for use in high-throughput screening and tissue and cell modeling; downloadable and recorded software for test systems for carrying out scientific investigations and experiments for use in the biotechnology, pharmaceutical fields, medicine, diagnostics chemical fields; downloadable and recorded computer programs for evaluating experimental data of tests on stem cell cultures of tissue cultures | ACTIVE | — |
| 042 | Research and development services in the field of information technology for the biotechnology, pharmacology, medicine, medical diagnostics, and chemistry industries; stem cell research; development of computer software for biotechnical, pharmaceutical and diagnostic use; development of biotechnical, pharmaceutical and diagnostic products and technical apparatus, namely, laboratory apparatus for research and industrial applications, apparatus and instruments for microscopy, microfluidic technology-based chips for high-throughput screening and data carriers; medical research; pharmaceutical research services; development of pharmaceutical preparations and medicines; provision of information and data relating to medical and veterinary research and development; computer programming in the medical field; development of computer platforms for screening in the field of medicine; development of chemical and biochemical assay system kits for biotechnological and chemical research purposes; development and establishment of testing specifications and procedures for use in the field of biotechnology, pharmacology, medicine, diagnostics, chemistry; development of software for test systems for use in the field of biotechnology, pharmacology, medicine, diagnostics, chemistry; scientific research and development in the field of diseases and disorders of the heart and in the heart development; scientific research and development of goods for the treatment of heart diseases | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 21, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 21, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 20, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 20, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 20, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 5, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 4, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 4, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 15, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 15, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 28, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 10, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 10, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 10, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 10, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 10, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 6, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 16, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 16, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 26, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 25, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 3, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |